G01N 2500/00
Screening for compounds of potential therapeutic value
G01N2500/00 (Screening for compounds of potential therapeutic value) appears on 7,225 US grants and 13,940 published applications in this corpus.
Search patents in G01N- Granted patents
- 7,225
- Published applications
- 13,940
- Assignees
- 3,990
- Inventors
- 23,412
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 11 | 0 |
| 1994 | 13 | 0 |
| 1995 | 15 | 0 |
| 1996 | 34 | 0 |
| 1997 | 60 | 0 |
| 1998 | 128 | 0 |
| 1999 | 123 | 0 |
| 2000 | 122 | 0 |
| 2001 | 151 | 51 |
| 2002 | 181 | 456 |
| 2003 | 175 | 1746 |
| 2004 | 180 | 756 |
| 2005 | 195 | 821 |
| 2006 | 294 | 826 |
| 2007 | 387 | 734 |
| 2008 | 409 | 603 |
| 2009 | 286 | 735 |
| 2010 | 373 | 678 |
| 2011 | 351 | 586 |
| 2012 | 308 | 501 |
| 2013 | 323 | 474 |
| 2014 | 334 | 504 |
| 2015 | 351 | 733 |
| 2016 | 307 | 605 |
| 2017 | 340 | 484 |
| 2018 | 331 | 389 |
| 2019 | 280 | 393 |
| 2020 | 283 | 361 |
| 2021 | 205 | 323 |
| 2022 | 171 | 290 |
| 2023 | 143 | 272 |
| 2024 | 118 | 237 |
| 2025 | 147 | 232 |
| 2026 | 84 | 150 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2500/10Involving cellsIndexing code2,237
- G01N 2500/04Screening involving studying the effect of compounds c directly on molecule aIndexing code1,866
- G01N 2500/02Screening involving studying the effect of compounds c on the interaction betweenIndexing code1,294
- G01N 2500/20Cell-free systemsIndexing code475
Recent patents
- Method for transducing protein-protein interactions6 Oct 2026US 12,753,403 B2ETH Zurich
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Maintenance and/or culture of tissue slices in vitro or ex vivo15 Sep 2026US 12,736,523 B2National University of Singapore
- Method and system for detecting cell-killing efficacy and/or immune activity, and application thereof8 Sep 2026US 12,730,104 B2Shanghai Ruiyu Biotech Co., Ltd.
- Multicyclic peptides and methods for their preparation1 Sep 2026US 12,723,059 B2Universiteit Van Amsterdam
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Methods and compositions for displaying peptide libraries8 Oct 2026US 2026/0308224 A1Board of Regents, The University of Texas System
- High throughput optical assay for screening hemoglobin oxygen affinity modifying drug8 Oct 2026US 2026/0309621 A1
- Compositions and methods for determining the effects of t cell engager8 Oct 2026US 2026/0309708 A1Arbele Limited
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
Most cited
By later US patents
- Automated sorting system for matrices with memory480US 6,329,139 B1Discovery Partners International, Inc. · 2001
- Matrices with memories406US 6,340,588 B12002
- Point-of-care fluidic systems and uses thereof394US 7,635,594 B2Theranos, Inc. · 2009
- Use of modified tethers in screening compound libraries330US 5,958,703 AGlaxo Group Limited · 1999
- Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1328US 7,595,048 B2Ono Pharmaceutical Co., Ltd. · 2009